Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SAN FRANCISCO, CA--(Marketwired - Jul 23, 2013) - TAYLOR, a full-service architectural, interiors and strategies firm, has announced the addition of two new leaders to its San Francisco...
-
ARLINGTON, VA--(Marketwired - Jul 17, 2013) - A new book, "Find the Lost Dollars: 6 Steps to Increase Profits in Architecture, Engineering, and Environmental Firms,"...
-
BOSTON, MA--(Marketwired - Jul 11, 2013) - The annual number of new drug approvals worldwide to treat neglected diseases has nearly doubled in recent years, with HIV/AIDS and malaria drugs...
-
IRVINE, CA--(Marketwired - Jun 26, 2013) - In its commitment to transforming the business of the healthcare experience, TAYLOR, a full-service healthcare design firm, adds Lance Carlson of Carlson...
-
LONDON--(Marketwired - Jun 12, 2013) - Sefaira, the leader in cloud-based software for sustainable building design, today announced that it received the EcoSummit Award 2013 Jury Gold. The award...
-
IRVINE, Calif., May 13, 2013 (GLOBE NEWSWIRE) -- Award-winning national firm KTGY Group, Inc., Architecture + Planning, announced today that the firm's Retail Studio has completed the design and...
-
BOSTON, MA--(Marketwired - May 7, 2013) - Clinical success rates for new cancer drugs doubled between the mid-1990s to the early 2000s, while the number of new cancer drugs entering clinical...
-
LOS ANGELES, April 25, 2013 (GLOBE NEWSWIRE) -- The Southern California Institute of Architecture (SCI-Arc) has received a $50,000 grant from the National Endowment for the Arts to support Design...
-
LOS ANGELES, April 11, 2013 (GLOBE NEWSWIRE) -- The Southern California Institute of Architecture (SCI-Arc) today announced that the Association of Collegiate Schools of Architecture (ACSA) designated...
-
BOSTON, MA--(Marketwired - Apr 9, 2013) - Growing protocol complexity -- responsible for longer clinical study times, greater difficulty in recruiting volunteers, and rising drug development costs...